• Press Releases.png

    Press Releases

OmniComm Systems® Common Stock Upgrades to Trade on OTCQX Best Marketplace

July 01, 2015


Dennis Constantinou
OmniComm Systems, Inc.

Fort Lauderdale, FL, July 1, 2015 - OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, announced today that it will begin trading on the OTCQX® Best Marketplace for established global and growth companies operated by OTC Markets Group Inc. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

”We are very pleased to be trading on the OTCQX® Best Marketplace,” stated Tom Vickers, CFO of OmniComm. “The upgrade to OTCQX will allow us to better serve our shareholders and increase OmniComm’s visibility to both institutional and retail investors. Both our current and future shareholders will benefit from the increased visibility, financial transparency and improved communications that result from the high standards of the OTCQX Best Marketplace.”

OmniComm’s president and COO, Stephen Johnson commented, “OmniComm is pleased to upgrade from OTCQB to OTCQX today, joining the other prestigious companies trading on the OTCQX Best Marketplace. This will provide our shareholders with a more efficient and transparent platform to follow OmniComm’s progress in the market.”

As the electronic data capture (EDC) specialists, OmniComm understands the power that an information-driven clinical enterprise can bring to clinical research organizations. OmniComm is the only company that provides a choice of best-of-breed EDC platforms that are purpose-built for their unique clinical research environments – Early Phase, Late Phase, Phase I-IV, device trials, Investigator Initiated. OmniComm provides the most advanced open and interoperable EDC platforms. Through innovative cloud technology and advanced API web services OmniComm provides clients with the information to make insight driven clinical data-based critical decisions, bringing medical therapies to patients faster with lower risk. 4 of the 5 top contract research organizations (CROs) and 7 of the 10 largest Phase I clinics run OmniComm EDC technologies.

About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,000 clinical trials. For more information, visit www.omnicomm.com.

OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.